Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024. "Gilead delivered another exceptionally ...
Updated recommendations were issued by the IAS-USA regarding the use of ART for treatment and prevention of HIV in adult populations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback